SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-032080
Filing Date
2024-07-02
Accepted
2024-07-02 06:30:27
Documents
50
Period of Report
2024-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20031962_8k.htm   iXBRL 8-K 49538
2 EXHIBIT 3.1 ef20031962_ex3-1.htm EX-3.1 96960
3 EXHIBIT 10.1 ef20031962_ex10-1.htm EX-10.1 410376
4 EXHIBIT 10.2 ef20031962_ex10-2.htm EX-10.2 134687
5 EXHIBIT 99.1 ef20031962_ex99-1.htm EX-99.1 10343
6 EXHIBIT 99.2 ef20031962_ex99-2.htm EX-99.2 27899
7 EXHIBIT 99.3 ef20031962_ex99-3.htm EX-99.3 52580
11 ef20031962_ex99-3slide1.jpg GRAPHIC 113553
12 ef20031962_ex99-3slide2.jpg GRAPHIC 294226
13 ef20031962_ex99-3slide3.jpg GRAPHIC 170579
14 ef20031962_ex99-3slide4.jpg GRAPHIC 126673
15 ef20031962_ex99-3slide5.jpg GRAPHIC 200123
16 ef20031962_ex99-3slide6.jpg GRAPHIC 142294
17 ef20031962_ex99-3slide7.jpg GRAPHIC 193244
18 ef20031962_ex99-3slide8.jpg GRAPHIC 155052
19 ef20031962_ex99-3slide9.jpg GRAPHIC 158253
20 ef20031962_ex99-3slide10.jpg GRAPHIC 152944
21 ef20031962_ex99-3slide11.jpg GRAPHIC 102705
22 ef20031962_ex99-3slide14.jpg GRAPHIC 167102
23 ef20031962_ex99-3slide15.jpg GRAPHIC 53955
24 ef20031962_ex99-3slide16.jpg GRAPHIC 164919
25 ef20031962_ex99-3slide17.jpg GRAPHIC 68734
26 ef20031962_ex99-3slide18.jpg GRAPHIC 169317
27 ef20031962_ex99-3slide19.jpg GRAPHIC 82504
28 ef20031962_ex99-3slide20.jpg GRAPHIC 119901
29 ef20031962_ex99-3slide21.jpg GRAPHIC 50810
30 ef20031962_ex99-3slide22.jpg GRAPHIC 133253
31 ef20031962_ex99-3slide23.jpg GRAPHIC 190382
32 ef20031962_ex99-3slide24.jpg GRAPHIC 144812
33 ef20031962_ex99-3slide25.jpg GRAPHIC 148917
34 ef20031962_ex99-3slide26.jpg GRAPHIC 145322
35 ef20031962_ex99-3slide27.jpg GRAPHIC 138983
36 ef20031962_ex99-3slide28.jpg GRAPHIC 144658
37 ef20031962_ex99-3slide29.jpg GRAPHIC 114897
38 ef20031962_ex99-3slide30.jpg GRAPHIC 169791
39 ef20031962_ex99-3slide31.jpg GRAPHIC 135642
40 image00001.jpg GRAPHIC 3851
41 image00003.jpg GRAPHIC 3810
  Complete submission text file 0001140361-24-032080.txt   6823001

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA rnac-20240701.xsd EX-101.SCH 3871
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnac-20240701_lab.xml EX-101.LAB 22691
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnac-20240701_pre.xml EX-101.PRE 16556
52 EXTRACTED XBRL INSTANCE DOCUMENT ef20031962_8k_htm.xml XML 4230
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 241092852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)